. Study: HIV drug of no benefit to hospitalized COVID patients - IOPAC Press "Enter" to skip to content

Second meeting of the International Health Regulations (2005) Emergency Committee regarding the upsurge of mpox 2024
- All WHO news
The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the second meeting of the International...
International Pathogen Surveillance Network announces first recipients of grants to better understand disease threats
- All WHO news
The World Health Organization (WHO) and partners announced 10 projects that will receive almost US$ 2 million in grants to...
The first-ever global oral health conference highlights universal health coverage by 2030
- All WHO news
Delegations from over 110 countries are coming together to produce national roadmaps and negotiate a joint declaration on oral health...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

Study: HIV drug of no benefit to hospitalized COVID patients

By iopac on October 6, 2020

Mary Van Beusekom | News Writer | CIDRAP NewsOct 06, 2020Lopinavir-ritonavir didn’t shorten hospital stay or lower the risk of mechanical ventilation or death.

Published in COVID-19

iopac

More from COVID-19More posts in COVID-19 »